{"disease":{"id":"type-1-facioscapulohumeral-muscular-dystrophy","name":"type 1 facioscapulohumeral muscular dystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04907162","title":"Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT05812144","title":"New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular Dystrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}